Cargando…
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
Proteomics is a rapidly advancing field not only in the field of biology but also in translational cancer research. In recent years, mass spectrometry and associated technologies have been explored to identify proteins or a set of proteins specific to a given disease, for the purpose of disease dete...
Autores principales: | Lu, Ming, Faull, Kym F., Whitelegge, Julian P., He, Jianbo, Shen, Dejun, Saxton, Romaine E., Chang, Helena R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717808/ https://www.ncbi.nlm.nih.gov/pubmed/19662217 |
Ejemplares similares
-
Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer
por: Lu, Ming, et al.
Publicado: (2010) -
Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response
por: He, Jianbo, et al.
Publicado: (2011) -
Targeting a Subset of the Membrane Proteome for Top–Down Mass Spectrometry: Introducing the Proteolipidome
por: Whitelegge, Julian
Publicado: (2020) -
Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021) -
Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)